Inhibition of NAMPT pathway by FK866 activates the function of p53 in HEK293T cells
Authors:
- Basant Kumar ThakurBTBasant Kumar Thakur
- Tino DittrichTDTino Dittrich
- Prakash ChandraPCPrakash Chandra
- Annette BeckerABAnnette Becker
- Yannick LippkaYLYannick Lippka
- Divakarvel SelvakumarDSDivakarvel Selvakumar
- Jan-Henning KlusmannJKJan-Henning Klusmann
- Dirk ReinhardtDRDirk Reinhardt
- Karl WelteKWKarl Welte
- 1 August 2012
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 424 (3) , 371-377
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applicationsImmunology & Cell Biology, 2011
- Posttranslational Modification of p53: Cooperative Integrators of FunctionCold Spring Harbor Perspectives in Biology, 2009
- Enzymes in the NAD+ Salvage Pathway Regulate SIRT1 Activity at Target Gene PromotersJournal of Biological Chemistry, 2009
- Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressorGenes & Development, 2006
- SV40 large T antigen targets multiple cellular pathways to elicit cellular transformationOncogene, 2005
- The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian CellsJournal of Biological Chemistry, 2004
- High throughput testing of the SV40 Large T antigen binding to cellular p53 identifies putative drugs for the treatment of SV40-related cancersVirology, 2003
- Association of SV40 with human tumoursSeminars in Cancer Biology, 2001
- Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.Genes & Development, 1992
- Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformed cells.Molecular and Cellular Biology, 1986